Please assess the completion status of the following clinical trial:

Trial Title: Treating PCOS With Digital Intervention vs. Metformin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Female aged 18- 45; Meet Rotterdam criteria; Insulin Resistance~Exclusion Criteria:~Women who are pregnant or have a pregnancy plan within six months; Congenital adrenocortical hyperplasia; Hyperprolactinemia; Hyperthyroidism or hypothyroidism; Abnormal liver function (≥ 3 times the upper limit of the normal range); Abnormal renal function (GFR\<60ml/min/1.73m2); Adrenal or ovarian tumors secreting androgens; Used contraceptives, metformin, pioglitazone, and antidepressant medication in the last 3 months.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Digital Intervention (Type: EXPERIMENTAL): A mini program-based digital intervention.
- Metformin (Type: ACTIVE_COMPARATOR): Traditional metformin monotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).